Sana biotechnology announces positive six-month clinical results from type 1 diabetes study of islet cell transplantation without immunosuppression

Groundbreaking first-in-human study establishes potential to treat type 1 diabetes by transplanting insulin-secreting cells without immunosuppression
SANA Ratings Summary
SANA Quant Ranking